We help life sciences and healthcare organizations transform fragmented, multi-modal data into harmonized, research-ready datasets. Built on our AI-enabled federated architecture and a global data partner network spanning 35+ countries, our solution accelerates discovery and evidence generation for an array of advanced use cases.
Rely on our extensive data network, which spans Europe, Japan, APAC, and the Americas, and connects hospitals, research organizations, and biobanks through a single federated ecosystem. We bring together public and private institutions across urban, suburban, and rural settings to ensure rapid access to diverse, high-quality datasets and enable secure collaboration.
Apply the industry’s most robust global health data, which includes structured and unstructured real-world data (RWD) from EMRs, labs, imaging, and genomics – all harmonized through and easily accessible via a federated ecosystem that enables access to diverse, high-quality, analysis-ready datasets.
Our harmonized, high-quality data powers research and innovation across the entire product lifecycle – spanning advanced use cases across from discovery to clinical development, launch, and post-launch evidence generation.
Why choose BC Platforms? Simply stated, we provision the data you need to improve speed to insight and inform a range of research, development, and commercial needs.
Maintain ownership and control of your data within a secure, federated architecture built for global privacy and security compliance. Our technology solutions ingest, harmonize, and integrate complex data sets that are provisioned in trusted research environments to enable collaboration and advanced analytics within and across teams.
Our AI-driven data mastering platform, BC Unify, ingests, harmonizes, anonymizes, and standardizes structured and unstructured multi-modal data from diverse sources. This ensures that every dataset is clean, compliant, and research-ready – creating a single, trusted foundation that powers our solutions.
Our trusted research environment (TRE) provides secure access and collaboration without technical complexity. It’s easy to use and manage, and integrates with existing analytical tools and workflows, reducing IT effort. Deployment is flexible via a TRE (federated options available).
We unite healthcare and life sciences around a single goal: transforming clinical data into the evidence that drives discovery and better outcomes for patients.
HEALTHCARE ORGANIZATIONS
Join our global data partner network and become part of a pioneering ecosystem that accelerates medical breakthroughs, enhances clinical decision-making, and drives personalized care across the most critical therapy areas.
LIFE SCIENCE COMPANIES
Access high-quality, diverse, harmonized real-world data to identify patient cohorts, assess treatment outcomes, and generate real-world evidence that supports clinical development, regulatory submissions, and commercial success.
For more than 25 years, BC Platforms has empowered healthcare and life sciences organizations to accelerate research and evidence generation through trusted data solutions.
Oncology (breast and lung)
Harmonized secondary real-world datasets from nine EU and APAC countries to support large-scale cross-country analysis of treatment patterns and biomarker testing with annual data refreshes for post-marketing studies.
Oncology (vaccine trials)
Integrated phenotype, omics, demographic, and clinical data within a federated environment to enable rapid, compliant patient matching and accelerate cohort recruitment by 60 percent across 100 institutions.
Rare disease (retrospective RWD study)
Mapped treatment pathways and harmonized multi-country datasets from 12 sites across the US, EU, UK, and Japan, delivering a regulatory-grade CDISC dataset supporting submission.
Oncology (NSCLC longitudinal RWD cohort)
Standardized longitudinal data from 1,000 NSCLC patients across 12 sites in the UK, Germany, and Spain within a federated environment, generating a robust dataset to support payer discussions and HTA evidence generation
NSCLC and HSNCC (AI model validation)
Provided multi-modal patient-level data from the US and EU, including clinical, imaging, and radiotherapy data, to support development and validation of the customer’s internal AI models.
Oncology (NSCLC)
Harmonized imaging, clinical, radiotherapy, and HCRU data from more than 2,000 patients across the US and EU, enabling faster multi-modal analysis, secure de-identification, and scalable collaboration.
BC Platforms meets the highest international standards for data protection, product quality, and ethical data governance. Our ISO-certified systems and compliance frameworks protect every stage of the data lifecycle, ensuring partners can innovate confidently and responsibly.
We partner with GeneVault to expand access to RWD from underrepresented populations across Asia, the Middle East, Africa, and Latin America.
BC Platforms in the press: Signify Research reviews BC Catalyst, our AI-powered platform for life sciences and precision medicine.
Narasimha Kumar joins us as Global Head of Technology Consulting and India Country Head.
Contact us to learn more about our solutions, see a live demo, or talk about how we can support your needs.